Table 11.

Aneurysm treatment prospective studies literature used for comparison

	HELPS Trial		MAPS Trial	Cerecyte Trial		CorPath GRX
Technical success	96.6 %		97.1 %	97.2 %		94.0 %
Intraprocedural aneurysm rupture	3.4 %		2.2 %	3.6 %		2.6 %
Thromboembolic complications	10.2 %		4.5 %	5.6 %		10.25 %
Mortality	2.2% at discharge		0.2% periprocedural	0.4% before discharge		0% at discharge
Raymond-Roy Scale postprocedure	Operator self-assessed		Core-laboratory review	Core-laboratory review		Core-laboratory review
1	47.5 %		36.1 %	26.2 %		64.5%
2	34.5 %		26.2 %	49.5 %		4.5 %
3	18.0 %		37.7 %	24.3 %		31.0 %
Clinical assessment at discharge	WFNS			mRS		mRS
	0	38.5 %		0	81.8 %	0	78.2 %
	1–2	55.3 %		1	15.9 %	1	17.9 %
	≥ 3	6.0 %		2	2.3 %	2	3.8 %
				≥ 3	0 %	≥ 3	0 %

mRS, modified Rankin Scale; WFNS, World Federation of Neurological Surgeons.